PDF: Janus Kinase and Tyrosine Kinase Inhibitors in Dermatology: A Review

PDF Download: Currently, JAK inhibitors are only FDA approved for dermatologic, rheumatologic, and hematologic conditions. Recent studies show the utility of JAK inhibitors in treating atopic dermatitis, psoriasis, psoriatic arthritis, vitiligo, and alopecia areata.